Enhanced TDS
Identification & Functionality
- Chemical Name
- Molecular formula
- C₃₇H₆₇NO₁₃
- Technologies
- Product Families
- Definition
Erythromycin consists primarily of erythromycin A (C37H67NO13). The sum of the percentages of erythromycin A, erythromycin B, and erythromycin C is not less than 85.0% and not more than 100.5%, calculated on the anhydrous basis.
- Chemical Structure
Properties
- Typical Properties
Value Units Test Method / Conditions Molecular Weight 733.94 - -
Regulatory & Compliance
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- USP Reference Standards
- USP Erythromycin RS
- USP Erythromycin B RS
- 12-Deoxyerythromycin; (3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12-dihydroxy-4 {[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione. C37H67NO12 717.94 (USP 1-Dec-2019)
- USP Erythromycin C RS
- 3′′-O-Demethylerythromycin; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-{[(2R,4R,5S,6S)-4,5-Dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione. C36H65NO13 719.91 (USP 1-Dec-2019)
- USP Erythromycin Related Compound N RS N-Demethylerythromycin A; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-Ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-6-{[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino) tetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-
Storage & Handling
- Storage Information
Preserve in tight containers.